$270 Million is the total value of Endurant Capital Management LP's 96 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 23.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGN | Sell | ALLERGAN PLC | $14,003,000 | -17.1% | 60,800 | -16.8% | 5.19% | -8.1% |
| ABT | Sell | ABBOTT LABS | $10,429,000 | -13.7% | 246,608 | -19.8% | 3.86% | -4.4% |
| HLS | Sell | HEALTHSOUTH CORP | $9,847,000 | -30.8% | 242,704 | -33.8% | 3.65% | -23.3% |
| AET | Sell | AETNA INC NEW | $9,659,000 | -16.0% | 83,665 | -11.1% | 3.58% | -6.8% |
| STJ | Sell | ST JUDE MED INC | $8,698,000 | -8.1% | 109,048 | -10.1% | 3.22% | +2.0% |
| MNKKQ | Sell | MALLINCKRODT PUB LTD CO | $8,421,000 | -41.0% | 120,674 | -48.6% | 3.12% | -34.6% |
| MCK | Sell | MCKESSON CORP | $7,716,000 | -41.5% | 46,272 | -34.5% | 2.86% | -35.1% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $6,147,000 | -28.3% | 258,298 | -29.6% | 2.28% | -20.5% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDadr | $6,139,000 | -47.0% | 133,433 | -42.1% | 2.28% | -41.2% |
| CNC | Sell | CENTENE CORP DEL | $6,072,000 | -16.6% | 90,688 | -11.1% | 2.25% | -7.5% |
| BIIB | Sell | BIOGEN INC | $5,457,000 | +9.9% | 17,432 | -15.1% | 2.02% | +21.9% |
| WMGI | Sell | WRIGHT MED GROUP N V | $4,650,000 | -53.2% | 189,578 | -66.9% | 1.72% | -48.1% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $4,016,000 | -35.0% | 29,212 | -38.4% | 1.49% | -27.9% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $3,290,000 | -56.9% | 20,686 | -60.0% | 1.22% | -52.3% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $2,983,000 | -9.7% | 35,788 | -10.7% | 1.11% | +0.1% |
| Sell | FLUIDIGM CORP DELnote 2.750% 2/0 | $2,517,000 | -42.2% | 4,161,000 | -42.7% | 0.93% | -35.9% | |
| JNJ | Sell | JOHNSON & JOHNSON | $1,996,000 | -32.8% | 16,900 | -31.0% | 0.74% | -25.5% |
| GILD | Sell | GILEAD SCIENCES INC | $1,646,000 | -29.1% | 20,810 | -25.2% | 0.61% | -21.3% |
| LHCG | Sell | LHC GROUP INC | $1,575,000 | -49.6% | 42,700 | -40.9% | 0.58% | -44.1% |
| A | Sell | AGILENT TECHNOLOGIES INC | $1,440,000 | -64.1% | 30,585 | -66.2% | 0.53% | -60.2% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $1,390,000 | -46.8% | 69,574 | -66.5% | 0.52% | -41.1% |
| NVRO | Sell | NEVRO CORP | $1,314,000 | -57.1% | 12,584 | -69.7% | 0.49% | -52.4% |
| AMGN | Sell | AMGEN INC | $1,311,000 | -67.2% | 7,858 | -70.1% | 0.49% | -63.7% |
| SPNC | Sell | SPECTRANETICS CORP | $1,305,000 | -71.4% | 52,026 | -78.6% | 0.48% | -68.2% |
| HRC | Sell | HILL ROM HLDGS INC | $1,190,000 | -33.7% | 19,200 | -46.1% | 0.44% | -26.5% |
| BKD | Sell | BROOKDALE SR LIVING INC | $1,031,000 | -47.5% | 59,070 | -53.5% | 0.38% | -41.8% |
| ANTM | Sell | ANTHEM INC | $981,000 | -70.3% | 7,829 | -68.9% | 0.36% | -67.0% |
| GI | Sell | ENDOCHOICE HLDGS INC | $971,000 | +17.1% | 121,663 | -28.1% | 0.36% | +30.0% |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $820,000 | -86.1% | 6,657 | -84.8% | 0.30% | -84.6% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $726,000 | -58.3% | 94,812 | -58.9% | 0.27% | -53.7% |
| BBH | Sell | VANECK VECTORS ETF TRbiotech etf | $709,000 | -57.5% | 6,150 | -62.3% | 0.26% | -52.9% |
| STE | Sell | STERIS PLC | $694,000 | -70.0% | 9,500 | -71.8% | 0.26% | -66.8% |
| ILMN | Sell | ILLUMINA INC | $630,000 | +16.0% | 3,470 | -10.3% | 0.23% | +28.6% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $618,000 | -3.6% | 12,200 | -13.5% | 0.23% | +7.0% |
| VRX | Sell | VALEANT PHARMACEUTICALS INTL | $550,000 | -31.9% | 22,400 | -44.1% | 0.20% | -24.4% |
| PEN | Sell | PENUMBRA INC | $547,000 | -45.6% | 7,200 | -57.4% | 0.20% | -39.6% |
| HZNP | Sell | HORIZON PHARMA PLC | $472,000 | -49.2% | 26,040 | -53.9% | 0.18% | -43.7% |
| INCY | Sell | INCYTE CORP | $471,000 | -29.1% | 5,000 | -39.8% | 0.18% | -21.2% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $449,000 | -16.5% | 5,150 | -17.6% | 0.17% | -7.8% |
| NLNK | Sell | NEWLINK GENETICS CORP | $447,000 | -36.5% | 29,791 | -52.3% | 0.17% | -29.4% |
| BAX | Sell | BAXTER INTL INC | $396,000 | -56.0% | 8,309 | -58.3% | 0.15% | -51.2% |
| Sell | TRILLIUM THERAPEUTICS INC | $361,000 | +47.3% | 24,400 | -10.6% | 0.13% | +63.4% | |
| RDUS | Sell | RADIUS HEALTH INC | $341,000 | +13.3% | 6,300 | -23.2% | 0.13% | +24.8% |
| BDX | Sell | BECTON DICKINSON & CO | $341,000 | -93.1% | 1,900 | -93.5% | 0.13% | -92.4% |
| RAD | Sell | RITE AID CORP | $136,000 | -70.0% | 17,700 | -70.8% | 0.05% | -67.1% |
| PMC | Exit | PHARMERICA CORP | $0 | – | -9,390 | -100.0% | -0.08% | – |
| ARA | Exit | AMERICAN RENAL ASSOCIATES HO | $0 | – | -8,500 | -100.0% | -0.08% | – |
| HUM | Exit | HUMANA INC | $0 | – | -1,798 | -100.0% | -0.11% | – |
| MTD | Exit | METTLER TOLEDO INTERNATIONAL | $0 | – | -1,100 | -100.0% | -0.13% | – |
| HWAY | Exit | HEALTHWAYS INC | $0 | – | -60,016 | -100.0% | -0.23% | – |
| AMPH | Exit | AMPHASTAR PHARMACEUTICALS IN | $0 | – | -48,825 | -100.0% | -0.26% | – |
| SSRG | Exit | SYMMETRY SURGICAL INC | $0 | – | -61,819 | -100.0% | -0.27% | – |
| WAT | Exit | WATERS CORP | $0 | – | -6,200 | -100.0% | -0.29% | – |
| PFE | Exit | PFIZER INC | $0 | – | -32,100 | -100.0% | -0.38% | – |
| EVHC | Exit | ENVISION HEALTHCARE HLDGS IN | $0 | – | -45,149 | -100.0% | -0.38% | – |
| MD | Exit | MEDNAX INC | $0 | – | -17,000 | -100.0% | -0.41% | – |
| NTUS | Exit | NATUS MEDICAL INC DEL | $0 | – | -48,400 | -100.0% | -0.61% | – |
| SRCL | Exit | STERICYCLE INC | $0 | – | -22,200 | -100.0% | -0.77% | – |
| FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -256,490 | -100.0% | -0.77% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.